Connect with us

Health

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab – The Lancet

Humoral and cell-mediated immune responses are blunted after SARS-CoV-2 vaccinationin patients with a history of CD20 B-cell-depleting…

Published

on

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending